跳至主要内容
临床试验/CTRI/2017/11/010516
CTRI/2017/11/010516招募中4 期

Effect of oxcarbazepine on serum Brain Derived Neurotrophic Factor (BDNF) in bipolar disorder

DR RITUPARNA MAITI0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All patients with the diagnosis of bipolar affective disorder (by ICD-10 DCR) current episode mania without psychotic symptoms
  • Patients aged 18-45 years, of either sex.
  • Patientswith baseline score >20 on the Young Mania Rating Scale (YMRS).
  • Patients who had not taken any treatment for at least 4 weeks before inclusion.

排除标准

  • Patients with bipolar disorder (by ICD-10 DCR) presenting during depressive/euthymic/mixed episode.
  • Patients who are already under treatment for the presenting conditions.
  • Rapid cycling in the past 12 months.
  • Previous history of refractoriness to carbazepine or oxcarbazepine.
  • Patients with comorbid substance abuse or history of organicity
  • Pregnant and nursing women, patients with history ofmajor medical or neurological illness.

研究者

发起方
DR RITUPARNA MAITI

相似试验